. 2020 Oct 19;35(6):1563–1570. doi: 10.1038/s41375-020-01056-6

Table 2.

Reports of donor CAR-T cells given for relapse of B-cell cancers after an allotransplant.

Subjects (N)	Age^a	B-ALL		T-ALL (CD19⁺)	B-CLL	Lymphoma				Ref.
Subjects (N)	Age^a	Ph¹⁺ or BCRABL1⁺	Ph¹⁻ or BCRABL1⁻	T-ALL (CD19⁺)	B-CLL	MCL	DLBCL	Follicular	Nodular HL	Ref.
8	32 (9–59)	2	2		4					[23]
10	52 (44–66)				4	4	2			[24]
16	50 (23–74)	4	12							[25]
9	39 (15–64)	5	4							[26]
20	46 (20–68)	1	4		5	5	5			[27]
26	40 (21–61)	17				1	4	3	1	[28]
30	14 (5–60)	2	27	1						[29]
6	27 (8–44)	1	5							[18]

Ph¹ Philadelphia1-chromosome, BCRABL1 qRT-PCR result, Ref reference.

^aYears (y); median; range.